Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment

Archives of Ophthalmology

Volumn 117, Issue 9, 1999, Pages 1137-1142

  Katz, Joanne ^a,c   Congdon, Nathan ^b   Friedman, David S ^b  

^a Johns Hophins School of Hygiene and Public Health ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VISUAL FIELD DEFECT;

EID: 0032822539     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.117.9.1137     Document Type: Article

References (27)

1. Brigatti L, Nouri-Mahdavi K, Weitzman M, Caprioli J. Automatic detection of glaucomatous visual field progression with neural networks. Arch Ophthalmol. 1997; 115:725-728.
2. Werner EB, Bishop Kl, Koelle J, et al. A comparison of experienced clinical observers and statistical tests in detection of progressive visual field loss in glaucoma using automated perimetry. Arch Ophthalmol. 1994:101:14451455.
3. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sei. 1996:37:1419-1428.
4. Birch MK, Wishart PK, O'Donnel NP. Determining progressive visual field loss in serial Humphrey visual fields. Ophthalmology. 1995:102:1227-1235.
5. . 5. Chauhan BC, Drance SM, Douglas GR. The use of visual field indicesïn detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sei. 1990;31 : 512-520.
6. Noureddin BN, Poinoosawmy D, Fitzke FW, Hitchings RA. Regression analysis of visual field progression in low tension glaucoma. Br J Ophthalmol. 1991 ;75: 493-495.
7. Fitzke FW, McNaught AI. The diagnosis of visual field progression in glaucoma. Curr Opin Ophthalmol. 1994:5:110-115.
8. Wild JM, Hussey MK, Flanagan JG, Trope GE. Pointwise topographical and longitudinal modeling of the visual field in glaucoma. Invest Ophthatmol Vis Sei. 1993:34:1907-1916.
9. Mandava S, Caprioli J, Zulauf M. Glaucoma Pattern Index to quantify'glaucomatous visual field loss. J Glaucoma. 1992;1:178-183.
10. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
11. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Comparison of methods to detect visual field progression in glaucoma. OpWte/motoaJ.1997;104:1228-1236.
12. McNaught AI, Crabb DP, Fitzke FW, Hitchings RA. Visual field progression: comparison of Humphrey Statpac 2 and poinhvise linear regression analysis. Graeles Arch Clin Exp Ophthalmol. 1996:234:411-418.
13. Fitzke FW, Hitchings RA, Poinoosawmy D, McNaught AI, Crabb DP. Analysis of visual field progression in glaucoma. BrJ Ophthalmol. 1996:80:40-48.
14. Viswanathan AC, Fitzke FW, Hitchings RA. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2. Br J Ophthalmol. 1997:81:1037-1042.
15. The Advanced Glaucoma Intervention Study Investigators. The Advanced Glaucoma Intervention Study, 2: visual field test scoring and reliability. Ophthalmol03y.1994;101:1445-1455.
16. The Advanced Glaucoma Intervention Study Investigators. The Advanced Glaucoma Intervention Study (AGIS), 3: baseline characteristics of black and white patients. Ophthalmology. 1998:105:1137-1145.
17. The Advanced Glaucoma Intervention Study Investigators. The Advanced Glaucoma Intervention Study (AGIS), 4: comparison of treatment outcomes within race: seven year results. Ophthalmology. 1998:105:1146-1164.
18. Katz J, Sommer A, Gaasterland DE, Anderson DR. Comparison of analytic algorithms for detecting glaucomatous visual field loss. Arch Ophthalmol. 1991 ;109: 1684-1689.
19. Katz J. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Ophthalmology. 1999:106:391-395.
20. Bengtsson B, Lindgren A, Heijl A, Lindgren G, Asman P, Patella M. Perimetric probability maps to separate change caused by glaucoma from that caused by cataract. Acta Ophthalmol Scand. 1997:75:184-188.
21. Sommer A, Quigley HA, Robin Al, et al. Evaluation of nerve fiber layer assessment. Arch Ophthalmol. 1984:102:1766-1771.
22. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous visual field loss. Arch Ophthalmol. 1991 ; 109:77-83.
23. Katz J, Sommer A. Reliability indexes of automated perimetric tests. Arch Ophthalmol. 1988;106:1252-1254.
24. Tielsch JM, Katz J, Quigley HA, Miller NR, Sommer A. Intraobserver and interobserver agreement in measurement of optic disc characteristics. Ophthalmology. 1988:95:350-356.
25. Hodapp E, Parrish RKII, Anderson DR. Clinical Decisions in Glaucoma. St Louis, Mo: Mosby-Year Book Inc; 1993.
26. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977:33:159-174.
27. Katz J, Quigley HA, Sommer A. Detection of incident field loss using the Glaucoma Hemifield Test. Ophthalmology. 1996:103:657-663.